Results 141 to 150 of about 48,625 (267)
Once-monthly risedronate for postmenopausal osteoporosis
, 2009 Kristina Casadei1, Carolyn Becker21Columbia University College of Physicians and Surgeons, New York, NY, USA; 2Brigham and Women’s Hospital, Division of Endocrinology, Diabetes, and Hypertension, Boston, MA, USAAbstract: Bisphosphonates are the
Carolyn Becker, Kristina Casadei
core
, 2009 Aim: To compare the effects of one year- long strontium ranelate (SR) and raloxiphene ( R) therapies on bone mineral densities (BMDs) in postmenopausal osteoporotic women.
Banu Kuran +4 more
core
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Osteosarcopenia, defined as the coexistence of osteoporosis and sarcopenia, is an emerging geriatric syndrome linked to the musculoskeletal decline associated with aging. It is correlated with an increased risk of falls, fractures, disability, and mortality.
Javeria Taj +6 more
wiley +1 more source
Comparison of Different Treatment Protocols in Postmenopausal Osteoporosis
, 2005 This study was planned to compare the effects of three different treatment protocols including calcitonin, calcium and Vit D on bone mineral density (BMD) of postmenauposal women.
Zühal E. Altay +4 more
core
Vascular Calcification: Mechanisms, Models, and Therapies
iNew Medicine, Volume 2, Issue 2, June 2026.ABSTRACT Vascular calcification represents an active multifactorial process that mirrors several key features of skeletal bone mineralization. Clinically, it is characterized by diminished arterial compliance and increased arterial wall stiffness, both of which serve as independent predictors of significant adverse cardiovascular events.
Wenya Zhu +5 more
wiley +1 more source
Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors
Objective: To determine the awareness and knowledge levels of osteoporosis in postmenopausal breast cancer survivors (PBCS) who have completed adjuvant chemoradiotherapy, are under hormonal therapy, or are being monitored, and to examine potentially ...
Lale Aktekin +4 more
core +1 more source
JOR SPINE, Volume 9, Issue 2, June 2026.Low‐magnitude high‐frequency vibration (LMHFV), with or without 17β‐oestradiol (E2), exacerbated papain‐induced bovine intervertebral disc degeneration, reducing cell viability, impairing matrix production, and increasing inflammation. E2 showed no protective effect against papain‐induced degeneration or LMHFV.
Jan Ulrich Jansen +9 more
wiley +1 more source
Management of postmenopausal osteoporosis.
Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2013 Osteoporosis (OP) is a systemic skeletal disease characterised by low bone mass and micro-architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Common sites of osteoporotic fractures are in the spine (vertebral), hip (proximal femur) or wrist (distal forearm).
Yeap SS, Hew FL, Chan SP
openaire +2 more sources
MedComm, Volume 7, Issue 6, June 2026.APOE is widely recognized for its role in neurodegeneration and cardiovascular disease, but its different genotypes also influence body composition, affecting obesity, bone density, and muscle mass, through their central role in lipid transport and metabolism.
Miriam Frosina +5 more
wiley +1 more source